STVN Insider Madhavan Balachandran Sells $26K of Stock
Insider Madhavan Balachandran sold 1,493 shares of Stevanato Group S.p.A. on June 15, 2026, continuing a string of insider transactions at the medical device maker.
Reviewed by automated data checks against the source filing. How we make and check alerts
Madhavan Balachandran sold 1,493 shares of Stevanato Group S.p.A. ($STVN) at an average price of $17.09, worth about $25,515.37, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is up 1.9% after 1 week, up 13.7% after 1 month and up 13.7% to date (from the $16.63 close on Jun 15, 2026).
STVN
Stevanato Group S.p.A.
Key Points
- Madhavan Balachandran sold 1,493 shares of Stevanato Group S.p.A. NYSE:STVN on June 15, 2026, at a price of $17.09 per share for a total value of $25,515.37.
- The stock recently traded near $18.39, sitting below its 50-day moving average of $20.98 and close to its 200-day moving average of $18.19.
- UBS maintained a neutral rating on the stock while lowering its price target from $28.00 to $23.00 on September 9, 2026, amid a consensus buy rating across Wall Street.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Madhavan Balachandran Sells Stevanato Group Shares
Madhavan Balachandran parted with 1,493 shares of Stevanato Group S.p.A. NYSE:STVN on June 15, 2026. The transaction took place at an average price of $17.09 per share, bringing the total value of the sale to $25,515.37. Executive transactions have kept company watchers busy through the middle of the year, following other recent reports of insider buying and selling.
Recent Insider Activity at the Medical Device Maker
The June 15 sale by Madhavan Balachandran follows several other trades by company leaders earlier in the month. On June 9, Chief Business Strategy Officer Mauro Stocchi traded 6,586 shares. A few days later on June 12, a group of insiders acquired stock, including Sue-Jean Lin, Karen Flynn, and Elisabetta Magistretti buying 4,975 shares each. Meanwhile, Chief Financial Officer Marco Dal Lago also parted with 7,997 shares on June 12, 2026.
Stock Performance and Moving Averages
Stevanato Group S.p.A. shares traded at $18.39 recently. The company currently carries a market capitalization of roughly $5.26 billion and a forward P/E ratio of 23.18, based on its expected future earnings. The shares have traded in a 52-week range between $12.89 and $27.99. The stock has spent recent weeks below its 50-day moving average of $20.98 while holding near its 200-day moving average of $18.19.
Analysts Set New Price Targets
Analysts set new price targets on September 9, 2026. UBS maintained its neutral rating on the stock while lowering its price target from $28.00 to $23.00. Across Wall Street, analysts hold a consensus buy recommendation on the company with a target mean price of $24.47 per share.
What Stevanato Group Does
Stevanato Group S.p.A. designs and manufactures products for the biopharmaceutical and healthcare sectors, providing drug containment tools like syringes, vials, and diagnostic equipment. The company operates facilities across multiple continents to serve medical device and life sciences clients.
Looking Ahead to November Earnings
Investors will look ahead to Stevanato Group's next earnings report, which is currently scheduled for November 5, 2026, as the company moves through the second half of the year.
Related Filing Alerts
Source: Madhavan Balachandran's Form 4 filing on $STVN (Jun 15, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts